The lack of effective pharmaceutical interventions for SARS-CoV-2 raises the possibility of COVID-19 recurrence. Preparing the general population to accept a vaccine with relatively low effectiveness may be difficult. For a 50% effective vaccine, being a healthcare worker was also associated with greater acceptance, aOR: 1.57 95%CI: 1.12, 2.20.Ĭonclusion: Acceptance of a COVID-19 vaccine was highly influenced by the baseline effectiveness of the vaccine. For a 95% effective vaccine, being a healthcare worker and having a higher perceived risk of COVID-19 infection were associated with higher acceptance, adjusted odds ratio (aOR): 2.01 95%CI: 1.01, 4.00 and aOR: 2.21 95%CI: 1.07, 4.59, respectively compared to civil servants, being retired was associated with less acceptance (aOR: 0.15 95%CI: 0.04, 0.63). Results: Among 1,359 respondents, 93.3% of respondents (1,268/1,359) would like to be vaccinated for a 95% effective vaccine, but this acceptance decreased to 67.0% (911/1,359) for a vaccine with 50% effectiveness. Using a logistic regression model, we assessed the associations between sociodemographic characteristics, exposure to COVID-19 information, or perceived risk of infection with acceptance of a hypothetical COVID-19 vaccine. Participants were asked if they would accept a free vaccine which was 95 or 50% effective. Methods: A cross-sectional online survey was conducted between March 25 and April 6, 2020. This study was conducted to assess the acceptance of a 50 or 95% effective COVID-19 vaccine, when it becomes available in southeast Asia, among the general population in Indonesia. Introduction: Several vaccine candidates are being clinically tested in response to the 2019 coronavirus disease (COVID-19) pandemic. Secara keseluruhan, pengawasan keamanan ketat masih diberlakukan pada pengembangan vaksin Ini pengembang vaksin sedang memiliki sumber daya dan atensi yang melimpah akibat tekanan pandemi. Mampu mempercepat pengembangan vaksin tanpa mengurangi pengawasan keamanannya. Pengunaan teknologi yang sudah ada serta pengerjaan beberapa tahap secara simultan Percepatan pengembangan vaksin COVID-19 saat ini sedang dilakukan dengan dukunganīeberapa faktor. Untuk menjawab keraguan itu, maka ulasan iniĭitulis. Keamanan vaksin saat pengembangannya dipercepat. Keseluruhan tahapnya seringkali memakan waktu tahunan. Terdapat tiga fase uji klinis yang harus dilewati vaksin sebelum dapat diedarkan. Vaksin sangatĭibutuhkan untuk mengakhiri pandemi ini karena sudah terbukti dapat memusnahkan sebuah penyakit, Beragam cara yang telah dilakukan untuk meringankan efek pandemi COVID-19 sayangnya hanyaĭapat memperlambat penyebaran virus dan meringankan dampak ekonomi di masyarakat.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |